News tagged with metastatic colorectal cancer

FOLFOXIRI plus bevacizumab ups outcome in metastatic CRC

(HealthDay)—For patients with untreated metastatic colorectal cancer, chemotherapy with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) plus bevacizumab improves outcome versus fluorouracil, ...

23 hours ago
popularity not rated yet | comments 0

Gobbling up poison: A method for killing colon cancer

These days, cancer researchers aim to design targeted and specific therapy – those that kill cancer but spare the surrounding tissue. Immunotoxins, which use cancer-targeted antibodies linked to deadly ...

Sep 08, 2014
popularity 5 / 5 (10) | comments 0

Adherence to cancer surveillance guidelines varies

(HealthDay) -- Insured breast cancer survivors have high rates of guideline-recommended recurrence testing and non-recommended metastatic testing, while only about half of colorectal cancer survivors undergo ...

Mar 30, 2012
popularity not rated yet | comments 0

Blacks have less access to cancer specialists, treatment

Researchers at the University of California, San Diego School of Medicine say metastatic colorectal cancer patients of African-American descent are less likely to be seen by cancer specialists or receive cancer treatments. ...

Nov 19, 2013
popularity not rated yet | comments 0

Dose-escalated cetuximab tolerated in colorectal cancer

(HealthDay) -- For patients with irinotecan-refractory metastatic colorectal cancer (CRC), dose escalation of cetuximab is well tolerated and may improve response and disease control rates, but patients experience ...

Jul 05, 2012
popularity not rated yet | comments 0

Regorafenib: Hint of minor added benefit

Regorafenib (trade name: Stivarga) has been approved in Germany since August 2013 for adults with metastatic colorectal cancer in whom previous treatments are no longer effective or for whom these alternatives are not an ...

Jan 10, 2014
popularity not rated yet | comments 0